Survival after intrapleural catheter (IPC) insertion for malignant pleural effusion (MPE): a retrospective audit of prognostic scoring tools in patients with MPE treated with an IPC in a district general hospital.

M. Shuvo (Colchester (Essex), United Kingdom), F. Jarvis (Colchester (Essex), United Kingdom), R. Lee (Colchester (Essex), United Kingdom), L. Wright (Colchester (Essex), United Kingdom), R. Badiger (Colchester (Essex), United Kingdom), P. Hawkins (Colchester (Essex), United Kingdom)

Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer

Session: Prognostic and predictive factors: treatment of lung cancer
Session type: E-poster session
Number: 1750

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Shuvo (Colchester (Essex), United Kingdom), F. Jarvis (Colchester (Essex), United Kingdom), R. Lee (Colchester (Essex), United Kingdom), L. Wright (Colchester (Essex), United Kingdom), R. Badiger (Colchester (Essex), United Kingdom), P. Hawkins (Colchester (Essex), United Kingdom). Survival after intrapleural catheter (IPC) insertion for malignant pleural effusion (MPE): a retrospective audit of prognostic scoring tools in patients with MPE treated with an IPC in a district general hospital.. 1750

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

A randomised controlled study comparing the outcomes of pleural nurse practitioner (NP) versus doctors trained to perform pleural procedures for management of pleural effusions Source: Annual Congress 2013 –Interventional pulmonology and pleural diseases Year: 2013
A 10-year experience of pleurodesis for malignant pleural effusion in a district general hospital Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010
Retrospective analysis of survival time in malignant pleural effusion requiring IPC insertion Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017
Determinants of survival in patients with malignant pleural mesothelioma (MPM) managed at a single institution in Liguria, Italy Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018
Pleurodesis after intrapleural catheter insertion is an independent factor for overall survival in patients with malignant pleural effusions Source: Annual Congress 2009 - New insights in biology and treatment of pleural tumours Year: 2009
Are patients with malignant pleural effusions being referred appropriately for surgical intervention? Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008
Management of pneumothorax: are we giving the right information to patients upon discharge – an observational study Source: Annual Congress 2007 - Pleural diseases Year: 2007
The survival prediction of malignant pleural effusion and the validation of LENT prognosis score in Thai patients. Source: International Congress 2017 – Pleural and mediastinal malignancies Year: 2017
The second therapeutic intervention in malignant effusion trial (TIME2): A randomised controlled trial to assess the efficacy and safety of patient controlled malignant pleural effusion drainage by indwelling pleural catheter compared to chest drain and talc slurry pleurodesis Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012
Outcome of early medical thoracoscopy in pleural infection. Source: International Congress 2018 – Pleural interventions Year: 2018
A review of outcomes of indwelling pleural catheters (IPC) for malignant pleural effusions (MPE) at the Cambridge Pleural unit UK Source: Annual Congress 2013 –Interventional pulmonology and pleural diseases Year: 2013
LENT Score: predicting the survival of malignant pleural effusion–a prospective study of three years Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019
Heterogeneous delivery of definitive interventions in malignant pleural effusions – results from a Danish survey. Source: International Congress 2019 – Pleural disease: applying the evidence Year: 2019
Specialist clinic for exudative pleural effusions (EPE) improves outcome Source: Annual Congress 2008 - Pleural diseases and interventions Year: 2008
The association between pleural fluid exposure and survival in malignant pleural mesothelioma: a retrospective cohort study in 761 patients Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications Year: 2020
Thoracoscopy to management of parapneumonic effusion (PPE) in pediatric patients Source: Eur Respir J 2002; 20: Suppl. 38, 538s Year: 2002
Survival of patients with malignant pleural effusions: a three-year prospective self-experience study Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018
An audit of intercostal chest drains for pleural effusions in a district general hospital in the UK Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010
Pleural effusions in medical ICU –prevalence, causes and clinical significance Source: Annual Congress 2009 - Pleural and parenchymal diseases Year: 2009
Thoracoscopic talc pleurodesis‘(TTP) safety and clinical efficacy in malignant pleural effusions (MPE) Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010